Bio Essence Corporation
BIOE
$0.215
-$0.0201-8.55%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -47.16% | -46.88% | -15.99% | 43.63% | -40.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -47.16% | -46.88% | -15.99% | 43.63% | -40.82% |
| Cost of Revenue | -48.31% | 79.06% | 378.53% | -6.51% | -82.94% |
| Gross Profit | 79.08% | -6.33% | 7.60% | -15.50% | -61.73% |
| SG&A Expenses | 34.40% | 78.24% | 110.62% | 27.04% | -40.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.49% | 85.73% | 135.22% | 18.36% | -55.75% |
| Operating Income | -31.65% | -138.05% | -196.60% | -54.37% | 30.94% |
| Income Before Tax | -211.68% | -91.32% | -185.35% | -52.28% | 19.39% |
| Income Tax Expenses | -100.00% | -100.00% | -4.00% | -4.00% | -21.88% |
| Earnings from Continuing Operations | -210.27% | -90.23% | -183.86% | -52.02% | 19.40% |
| Earnings from Discontinued Operations | 256.23% | 256.23% | 256.23% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.79% | 32.59% | 12.75% | -20.02% | -44.27% |
| EBIT | -31.65% | -138.05% | -196.60% | -54.37% | 30.94% |
| EBITDA | -37.84% | -145.15% | -197.49% | -55.35% | 28.06% |
| EPS Basic | -36.75% | 40.77% | 21.49% | -9.39% | -36.06% |
| Normalized Basic EPS | -41.67% | -71.25% | -159.32% | -38.38% | 42.86% |
| EPS Diluted | -36.75% | 40.77% | 21.49% | -9.39% | -36.06% |
| Normalized Diluted EPS | -41.67% | -71.25% | -159.32% | -38.38% | 42.86% |
| Average Basic Shares Outstanding | 8.10% | 12.14% | 11.09% | 7.31% | 5.08% |
| Average Diluted Shares Outstanding | 8.10% | 12.14% | 11.09% | 7.31% | 5.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
